How the digitalization of pharmacy is transforming patient care.
With a record number of innovative drugs queued for FDA approval, managed healthcare executives have an eye toward innovative new products that tackle difficult conditions.
With a country-wide focus on reducing the cost of prescription drugs, managed healthcare executives make their forecasts concerning the future of list prices.
How the right benefit design can help increase patient engagement and adherence to key maintenance therapies.
The rare disease community struggles to balance care with costs.
These are the important policies to watch out for in 2019.
CMS introduced indication-based formularies as a voluntary tool for plans to implement in 2020.
How to manage drug cost in a value-based world.
Managed Healthcare Executive’s Managed Care Pharmacy Survey identifies different ways specialty pharmacy stakeholders believe they can reduce industry costs moving forward.
New study compares every state using data like opioid prescriptions and overdose rates to determine where drug problems hit hardest.